News

LGC appoints Marcus Kaeller as Chief Financial Officer

Pioneering Cancer Treatments through Enhanced Genomic Profiling in the GenomeMET Project

The National Measurement Laboratory and UK NEQAS for Leucocyte Immunophenotyping announce collaboration to improve quality assessment schemes for Chronic Myeloid Leukaemia Minimal Residual Disease testing.

New laboratory officially opened by David Willetts, UK Minister for Universities and Science.

LGC Biosearch Technologies™ launches a groundbreaking nucleic acid extraction method, sbeadex™ Lightning. This groundbreaking product rapidly delivers high-purity DNA in high-yields, typically achieving results in 5 minutes

LGC announces half year trading results

LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.  

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.

LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.

The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.

Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories